We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+5.86%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$2.49B
AUM Growth
+$579M
Cap. Flow
+$527M
Cap. Flow %
21.2%
Top 10 Hldgs %
10.5%
Holding
629
New
163
Increased
158
Reduced
137
Closed
121

Top Buys

Rank Stock Value
1
MAS icon
Masco
MAS
+$26M
2
GLW icon
Corning
GLW
+$25.6M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$24.4M
4
MELI icon
Mercado Libre
MELI
+$24.4M
5
BALL icon
Ball Corp
BALL
+$24.2M

Sector Composition

Rank Sector Weight
1 Technology 17.18%
2 Consumer Discretionary 16.51%
3 Healthcare 15.9%
4 Financials 14.42%
5 Industrials 11.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RELY
501
DELISTED
Real Industry, Inc.
RELY
$112K ﹤0.01%
38,600
LAB icon
502
Standard BioTools
LAB
$326M
$110K ﹤0.01%
27,300
+9,800
+56% +$46.5K
UCFC
503
DELISTED
United Community Financial Corp
UCFC
$101K ﹤0.01%
12,115
PRCP
504
DELISTED
Perceptron Inc
PRCP
$99K ﹤0.01%
+13,600
New +$108K
TCS
505
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
$91K ﹤0.01%
+1,027
New +$73.8K
AUDC icon
506
AudioCodes
AUDC
$244M
$82K ﹤0.01%
13,704
-4,600
-25% -$30K
SKIS
507
DELISTED
Peak Resorts, Inc.
SKIS
$74K ﹤0.01%
18,000
+3,500
+24% +$17.6K
ARDX icon
508
Ardelyx
ARDX
$1.24B
$58K ﹤0.01%
+11,400
New +$96.7K
AAOI icon
509
Applied Optoelectronics
AAOI
$8.04B
-340,500
Closed -$19.1M
ADVM
510
DELISTED
Adverum Biotechnologies
ADVM
-3,455
Closed -$93K
AGO icon
511
Assured Guaranty
AGO
$3.78B
-46,726
Closed -$1.73M
ALTO icon
512
Alto Ingredients
ALTO
$360M
-96,100
Closed -$658K
OSG
513
Octave Specialty Group
OSG
$252M
-39,500
Closed -$745K
AMD icon
514
Advanced Micro Devices
AMD
$851B
-4,044,756
Closed -$58.9M
AME icon
515
Ametek
AME
$55.5B
-147,800
Closed -$7.99M
AN icon
516
AutoNation
AN
$6.97B
-327,600
Closed -$13.9M
ASMB icon
517
Assembly Biosciences
ASMB
$506M
-1,200
Closed -$367K
DCH
518
Dauch Corp
DCH
$1.3B
-30,502
Closed -$573K
CAR icon
519
Avis
CAR
$5.63B
-59,790
Closed -$1.77M
CHTR icon
520
Charter Communications
CHTR
$14.7B
-31,600
Closed -$10.3M
CLB icon
521
Core Laboratories
CLB
$538M
-59,100
Closed -$6.83M
CLDX icon
522
Celldex Therapeutics
CLDX
$2.77B
-21,247
Closed -$1.15M
CLF icon
523
Cleveland-Cliffs
CLF
$6.81B
-1,230,787
Closed -$10.1M
CLSD
524
DELISTED
Clearside Biomedical
CLSD
-4,487
Closed -$534K
COTY icon
525
Coty
COTY
$2.33B
-70,052
Closed -$1.27M

Similar funds

PDT Partners's Q2 2017 Portfolio in Review

As of Q2 2017, PDT Partners held 629 positions worth $2.49B, up 30% from $1.91B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

PDT Partners deployed $527M of net new capital in Q2 2017, opening 163 new positions and adding to 158 existing holdings. Its largest new stake was Masco: 709,834 shares worth $27.1M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Magna International, an estimated $8.65M trimmed.

  • PDT Partners's largest Q2 2017 buy was Masco: 709,834 shares worth $27.1M.
  • PDT Partners added most to Mercado Libre in Q2 2017, an estimated $24.4M increase.
  • PDT Partners's biggest Q2 2017 reduction was Magna International, cutting an estimated $8.65M.
  • PDT Partners fully exited Advanced Micro Devices in Q2 2017, selling an estimated $58.9M.
  • PDT Partners's ten largest holdings make up 11% of its $2.49B portfolio in Q2 2017.
  • PDT Partners opened 163 new positions and closed 121 in Q2 2017.
  • PDT Partners's portfolio value rose 30% quarter-over-quarter to $2.49B.

Based on PDT Partners's 13F filing for Q2 2017, filed 14 Aug 2017.